Latest Amyris Inc (AMRS) Headlines Can Amyris I
Post# of 91
Posted On: 03/13/2014 5:09:59 AM
Latest Amyris Inc (AMRS) Headlines
Can Amyris Inc. Save Deep-Sea Sharks and Expand This Market by 230%?
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Mar 12, 9:32PM CDT
Blue sharks have been identified as the culprits of 13 attacks on humans in the last 430 years, according to the International Shark Attack File. There are likely more attacks that have not been reported or successfully identified, but don't worry --...
Hot Stock: Amyris, Shares Drop 9.1% (AMRS)
Comtex SmarTrend(R) - Fri Mar 07, 11:41AM CST
Amyris (NASDAQ:AMRS) is one of today's worst performing low-priced stocks, down 9.1% to $4.41 on 1.2x average daily volume. Thus far today, Amyris has traded 698,000 shares, vs. average volume of 574,000 shares per day. The stock has underperformed the Dow (-9.1% to the Dow's 0.2%) and underperformed the S&P 500 (-9.1% to the S&P's 0.0%) during today's trading.
Dividend Increases, Share Price Movements, Expanding Product Portfolios, and Strategic Collaborations - Analyst Notes on Rockwood, Methanex, Albemarle, PolyOne, and Amyris
PR Newswire - Thu Mar 06, 10:36AM CST
Editor Note: For more information about this release, please scroll to bottom.
How Designer Microbes and the Organism Industry Will Reshape Our World
Maxx Chatsko, The Motley Fool - Motley Fool - Sun Mar 02, 12:50PM CST
By the end of the decade, products created from microorganisms will be in 90% of American households. Source: Amyris. What would a computer be without transistors? Well, not much. A similar question can be asked of next-generation industrial...
Solazyme Follows Amyris Results With Impressive Developments of Its Own
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Feb 27, 1:20PM CST
This will be a busy year for next-generation industrial biotech platforms enabled by synthetic biology. Things started with a bang earlier this week when synthetic biology pioneer Amyris announced that it had achieved impressive progress exiting...
QEP Resources Down after Falling Short of Consensus; Amyris Inc. Shares Jump after Positive Forecast
ACCESSWIRE - Thu Feb 27, 12:16AM CST
QEP Resources, Inc. (NYSE: QEP) - For an in-depth report on QEP Resources, Inc. follow: www.BullTrends.com/stockquote/QEP
IFF-Amyris Alliance Enters 2nd Phase - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 5:50PM CST
On successfully completing the first phase of development, International Flavors & Fragrances Inc. extended its collaboration with Amyris, Inc. (AMRS) into the second phase for the development of specific renewable fragrance ingredients.
Why Anika Therapeutics, Amyris, and ExamWorks Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Wed Feb 26, 4:15PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. The recipe for market weakness remains the same yet again --...
Attention, Solazyme Investors: Don't Forget About Amyris
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Feb 26, 10:14AM CST
What do investors love about industrial biotech company Solazyme ? It offers the potential for tremendous growth -- from revenue of nearly $50 million in 2013 to more than $1 billion in the next several years -- and possesses a truly disruptive...
Traders Get Bullish on Shares of Amyris, Shares Up 16.7% (AMRS)
Comtex SmarTrend(R) - Wed Feb 26, 10:12AM CST
Amyris (NASDAQ:AMRS) is one of today's best performing low-priced stocks, up 16.7% to $4.20 on 1.8x average daily volume. Thus far today, Amyris has traded 928,000 shares, vs. average volume of 514,000 shares per day. The stock has outperformed the Dow (16.7% to the Dow's 0.2%) and outperformed the S&P 500 (16.7% to the S&P's 0.2%) during today's trading.
Upgrade Alert for Amyris (AMRS)
Comtex SmarTrend(R) - Wed Feb 26, 7:58AM CST
Amyris (NASDAQ:AMRS) was upgraded from Underperform to Market Perform at Cowen and Company today. The stock closed yesterday at $3.60 on volume of 460,000 shares, below average daily volume of 514,000. In the past 52 weeks, shares of Amyris have traded between a low of $2.17 and a high of $6.11 and closed yesterday at $3.60, which is 66% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 1.4%.
Amyris Reports Fourth Quarter and Year-End 2013 Financial Results
GlobeNewswire - Tue Feb 25, 3:03PM CST
Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today announced financial results for the fourth quarter and year ended December 31, 2013 and provided forward looking guidance for 2014.
IFF and Amyris Advance Innovative Collaboration to Develop Ingredients for the Flavors and Fragrances Market
GlobeNewswire - Tue Feb 25, 7:30AM CST
Amyris Successfully Meets Technical Milestones of Phase 1 R&D Development
Amyris, Inc. Announces Plans to Increase Production Capacity by 400%
Maxx Chatsko, The Motley Fool - Motley Fool - Sat Feb 22, 12:56PM CST
Synthetic biology pioneer Amyris quietly announced its intentions to increase production capacity by 400% by the end of the decade. It wasn't a starry-eyed prediction, either: Brazilian sugarcane producer Sao Martinho S.A. signed on to an amended...
How Solazyme, Inc. and Amyris, Inc. Bring Stability to a Risky World
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Feb 20, 9:57AM CST
Solazyme and Amyris should be on everyone's investing radar in 2014. The industrial biotech duo is utilizing synthetic biology to create renewable products with unparalleled quality, consistency, and reliability at commercial scale (that's the...
Big Companies Are Buying Into Biofuels
Shamus Funk, The Motley Fool - Motley Fool - Sun Feb 16, 2:52PM CST
A handful of smaller companies like Solazyme , Amyris , and Renewable Energy Group are often credited as being the future of biofuels, while many experts in the biofuel industry argue that a monumental investment would be necessary for biofuels...
Solazyme, Inc. and Amyris, Inc. Will Make Sluggish Economic Growth a Distant Memory
Maxx Chatsko, The Motley Fool - Motley Fool - Fri Feb 14, 2:00PM CST
Solazyme and Amyris are disrupting the world's approach to manufacturing commodity chemicals, specialty chemicals, and fuels. Their industrial biotech platforms create drop-in renewable products from engineered industrial organisms that can...
Can Shark Liver Oil Boost Biofuels?
Shamus Funk, The Motley Fool - Motley Fool - Fri Feb 07, 8:02AM CST
Amyris announced today a new partnership with Dowell C&I Co., Ltd. to distribute its Neossance Squalane product in the Republic of Korea. Demand for the renewable squalane in Asia has been strong, but is a specialty chemical commonly extracted...
Amyris Continues to Expand Sales of Squalane in Asia
GlobeNewswire - Thu Feb 06, 6:59AM CST
Amyris (Nasdaq:AMRS), a leading renewable products company, announced today the selection of Dowell C&I Co., Ltd., a supplier of ingredients for the personal care industry, as its exclusive distributor of Neossance(TM) Squalane in the Republic of Korea.
Can Solazyme Inc Successfully Scale Biology?
Maxx Chatsko, The Motley Fool - Motley Fool - Mon Feb 03, 9:12AM CST
Solazyme recently announced that it had started ramping commercial operations at its first industrial scale facility in Clinton, Iowa. The biorefinery will sport an annual nameplate capacity of 20,000 metric tons of renewable oils or biomass...
Can Amyris Inc. Save Deep-Sea Sharks and Expand This Market by 230%?
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Mar 12, 9:32PM CDT
Blue sharks have been identified as the culprits of 13 attacks on humans in the last 430 years, according to the International Shark Attack File. There are likely more attacks that have not been reported or successfully identified, but don't worry --...
Hot Stock: Amyris, Shares Drop 9.1% (AMRS)
Comtex SmarTrend(R) - Fri Mar 07, 11:41AM CST
Amyris (NASDAQ:AMRS) is one of today's worst performing low-priced stocks, down 9.1% to $4.41 on 1.2x average daily volume. Thus far today, Amyris has traded 698,000 shares, vs. average volume of 574,000 shares per day. The stock has underperformed the Dow (-9.1% to the Dow's 0.2%) and underperformed the S&P 500 (-9.1% to the S&P's 0.0%) during today's trading.
Dividend Increases, Share Price Movements, Expanding Product Portfolios, and Strategic Collaborations - Analyst Notes on Rockwood, Methanex, Albemarle, PolyOne, and Amyris
PR Newswire - Thu Mar 06, 10:36AM CST
Editor Note: For more information about this release, please scroll to bottom.
How Designer Microbes and the Organism Industry Will Reshape Our World
Maxx Chatsko, The Motley Fool - Motley Fool - Sun Mar 02, 12:50PM CST
By the end of the decade, products created from microorganisms will be in 90% of American households. Source: Amyris. What would a computer be without transistors? Well, not much. A similar question can be asked of next-generation industrial...
Solazyme Follows Amyris Results With Impressive Developments of Its Own
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Feb 27, 1:20PM CST
This will be a busy year for next-generation industrial biotech platforms enabled by synthetic biology. Things started with a bang earlier this week when synthetic biology pioneer Amyris announced that it had achieved impressive progress exiting...
QEP Resources Down after Falling Short of Consensus; Amyris Inc. Shares Jump after Positive Forecast
ACCESSWIRE - Thu Feb 27, 12:16AM CST
QEP Resources, Inc. (NYSE: QEP) - For an in-depth report on QEP Resources, Inc. follow: www.BullTrends.com/stockquote/QEP
IFF-Amyris Alliance Enters 2nd Phase - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 5:50PM CST
On successfully completing the first phase of development, International Flavors & Fragrances Inc. extended its collaboration with Amyris, Inc. (AMRS) into the second phase for the development of specific renewable fragrance ingredients.
Why Anika Therapeutics, Amyris, and ExamWorks Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Wed Feb 26, 4:15PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. The recipe for market weakness remains the same yet again --...
Attention, Solazyme Investors: Don't Forget About Amyris
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Feb 26, 10:14AM CST
What do investors love about industrial biotech company Solazyme ? It offers the potential for tremendous growth -- from revenue of nearly $50 million in 2013 to more than $1 billion in the next several years -- and possesses a truly disruptive...
Traders Get Bullish on Shares of Amyris, Shares Up 16.7% (AMRS)
Comtex SmarTrend(R) - Wed Feb 26, 10:12AM CST
Amyris (NASDAQ:AMRS) is one of today's best performing low-priced stocks, up 16.7% to $4.20 on 1.8x average daily volume. Thus far today, Amyris has traded 928,000 shares, vs. average volume of 514,000 shares per day. The stock has outperformed the Dow (16.7% to the Dow's 0.2%) and outperformed the S&P 500 (16.7% to the S&P's 0.2%) during today's trading.
Upgrade Alert for Amyris (AMRS)
Comtex SmarTrend(R) - Wed Feb 26, 7:58AM CST
Amyris (NASDAQ:AMRS) was upgraded from Underperform to Market Perform at Cowen and Company today. The stock closed yesterday at $3.60 on volume of 460,000 shares, below average daily volume of 514,000. In the past 52 weeks, shares of Amyris have traded between a low of $2.17 and a high of $6.11 and closed yesterday at $3.60, which is 66% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 1.4%.
Amyris Reports Fourth Quarter and Year-End 2013 Financial Results
GlobeNewswire - Tue Feb 25, 3:03PM CST
Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today announced financial results for the fourth quarter and year ended December 31, 2013 and provided forward looking guidance for 2014.
IFF and Amyris Advance Innovative Collaboration to Develop Ingredients for the Flavors and Fragrances Market
GlobeNewswire - Tue Feb 25, 7:30AM CST
Amyris Successfully Meets Technical Milestones of Phase 1 R&D Development
Amyris, Inc. Announces Plans to Increase Production Capacity by 400%
Maxx Chatsko, The Motley Fool - Motley Fool - Sat Feb 22, 12:56PM CST
Synthetic biology pioneer Amyris quietly announced its intentions to increase production capacity by 400% by the end of the decade. It wasn't a starry-eyed prediction, either: Brazilian sugarcane producer Sao Martinho S.A. signed on to an amended...
How Solazyme, Inc. and Amyris, Inc. Bring Stability to a Risky World
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Feb 20, 9:57AM CST
Solazyme and Amyris should be on everyone's investing radar in 2014. The industrial biotech duo is utilizing synthetic biology to create renewable products with unparalleled quality, consistency, and reliability at commercial scale (that's the...
Big Companies Are Buying Into Biofuels
Shamus Funk, The Motley Fool - Motley Fool - Sun Feb 16, 2:52PM CST
A handful of smaller companies like Solazyme , Amyris , and Renewable Energy Group are often credited as being the future of biofuels, while many experts in the biofuel industry argue that a monumental investment would be necessary for biofuels...
Solazyme, Inc. and Amyris, Inc. Will Make Sluggish Economic Growth a Distant Memory
Maxx Chatsko, The Motley Fool - Motley Fool - Fri Feb 14, 2:00PM CST
Solazyme and Amyris are disrupting the world's approach to manufacturing commodity chemicals, specialty chemicals, and fuels. Their industrial biotech platforms create drop-in renewable products from engineered industrial organisms that can...
Can Shark Liver Oil Boost Biofuels?
Shamus Funk, The Motley Fool - Motley Fool - Fri Feb 07, 8:02AM CST
Amyris announced today a new partnership with Dowell C&I Co., Ltd. to distribute its Neossance Squalane product in the Republic of Korea. Demand for the renewable squalane in Asia has been strong, but is a specialty chemical commonly extracted...
Amyris Continues to Expand Sales of Squalane in Asia
GlobeNewswire - Thu Feb 06, 6:59AM CST
Amyris (Nasdaq:AMRS), a leading renewable products company, announced today the selection of Dowell C&I Co., Ltd., a supplier of ingredients for the personal care industry, as its exclusive distributor of Neossance(TM) Squalane in the Republic of Korea.
Can Solazyme Inc Successfully Scale Biology?
Maxx Chatsko, The Motley Fool - Motley Fool - Mon Feb 03, 9:12AM CST
Solazyme recently announced that it had started ramping commercial operations at its first industrial scale facility in Clinton, Iowa. The biorefinery will sport an annual nameplate capacity of 20,000 metric tons of renewable oils or biomass...
(0)
(0)Amyris, Inc. (AMRS) Stock Research Links
Scroll down for more posts ▼